Medicine information STRIVERDI RESPIMAT 2.5mcg inhalation solution

Product code:
W60771005
Quantity:
3
Indicated for:
chronic obstructive pulmonary disease
Route of administration:
inhalation
Substance:
olodaterol (beta-2 adrenergic agonist)
ATC
R03AC19 — Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists
Olodaterol is a long-acting beta-2 adrenergic agonist used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the smooth muscles of the airways, making breathing easier.

The medication is administered via an inhaler, usually once daily, as directed by a doctor. It is important for patients to use the medication regularly to achieve maximum benefits.

Patients should be aware of potential side effects, such as tremors, palpitations, or headaches. It is important to inform the doctor of any unusual symptoms.

Common side effects include tremors, palpitations, headaches, and dry mouth. In rare cases, severe reactions such as paradoxical bronchospasm or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about STRIVERDI RESPIMAT 2.5mcg

Substance:
olodaterol
Date of latest medicines list:
01-07-2021
Product code:
W60771005
Strength:
2.5mcg
Pharmaceutical form:
inhalation solution
Quantity:
3
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA
Holder:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA
Number:
11140/2018/02
Shelf life:
3 years-; after the first opening a cartusului - 3 months; dupa prima utilizare a inhalatorului- 1an

Combinations with other substances

Official documents

The correspondence between the document and the displayed text is unconfirmed.

Source institution
ANMDMR
Document language
Romanian

Warnings:

Hyperglycemia

This medicine may increase blood sugar.

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.